Aspira Women’s Health (OTC: AWHL) publishes investor slide deck

Rhea-AI Filing Summary

Aspira Women’s Health Inc. filed a current report to note that it has shared updated investor information with the market. On December 29, 2025, the company published an investor presentation on its website, providing a slide deck that outlines its business and related information for shareholders and other stakeholders. This slide deck is included as Exhibit 99.1 to the report. The filing is made under Regulation FD, which is intended to ensure that all investors have access to the same key information at the same time.

Aspira Women's Health Inc.0000926617false00009266172025-12-292025-12-29

​

​

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

FORM 8-K

CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d)

OF THE SECURITIES EXCHANGE ACT OF 1934

Date of Report (Date of earliest event reported): December 29, 2025

ASPIRA WOMEN’S HEALTH INC.

(Exact name of registrant as specified in its charter)

​

​	​	​	​	​
Delaware	​ ​ ​	001-34810	​ ​ ​	33-0595156
(State or other jurisdiction of	​	(Commission	​	(IRS Employer
incorporation or organization)	​	File Number)	​	Identification No.)

​

12117 Bee Caves Road, Building III, Suite 100

Austin, TX 78738

(Address of principal executive office) (Zip Code)

(512) 519-0400

(Registrants’ telephone number, including area code)

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

​	​
☐	Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
​	​
☐	Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
​	​
☐	Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
​	​
☐	Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

​

Securities registered pursuant to Section 12(b) of the Act:

​

​	​	​	​	​
Title of each class	​ ​ ​	Trading Symbol(s)	​ ​ ​	Name of each exchange on which registered
Common Stock, par value $0.001	​	AWHL	​	OTC QX Market

​

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter)

Emerging Growth Company ☐

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

​

​

​

Item 7.01 Regulation FD Disclosure.

​

On December 29, 2025, Aspira Women’s Health Inc. (the “Company”) published an investor presentation on its website. A copy of the investor presentation is furnished as Exhibit 99.1 to this Current Report filing on Form 8-K.

​

Item 9.01 Financial Statements and Exhibits

(d) Exhibits.

​	​	​
Exhibit No.	​ ​ ​	Description
99.1	​	Slide Deck Published by Aspira Women’s Health On December 29, 2025
104	​	Cover Page Interactive Data File (embedded within the Inline XBRL document).

​

​

​

​

​

​

​

​

​

​

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.

Dated: December 31, 2025

​

	ASPIRA WOMEN’S HEALTH INC.
	By:	/s/ Michael Buhle
	Name:	Michael Buhle
	Title:	Chief Executive Officer

​

​

​

FAQ

What did Aspira Women’s Health Inc. (AWHL) disclose in this 8-K?

Aspira Women’s Health Inc. disclosed that it published an investor presentation on its website on December 29, 2025, and furnished the slide deck as Exhibit 99.1.

Why did Aspira Women’s Health Inc. furnish an investor presentation?

The company furnished the investor presentation under Regulation FD to provide broad, simultaneous access to the information contained in its slide deck for investors and the public.

Where can investors find the Aspira Women’s Health Inc. slide deck mentioned in the 8-K?

The slide deck was published on the company’s website and is also attached to the report as Exhibit 99.1 titled “Slide Deck Published by Aspira Women’s Health On December 29, 2025.”

What exhibits are included in this Aspira Women’s Health Inc. 8-K filing?

The report includes Exhibit 99.1, which is the investor slide deck, and Exhibit 104, the cover page interactive data file embedded within the Inline XBRL document.

Who signed the Aspira Women’s Health Inc. 8-K filed around December 31, 2025?

The report was signed on behalf of Aspira Women’s Health Inc. by Michael Buhle, who is the company’s Chief Executive Officer.

On which market is Aspira Women’s Health Inc. common stock traded?

Aspira Women’s Health Inc. common stock, par value $0.001 per share, is listed on the OTC QX Market under the trading symbol AWHL.